Feb 25, 2020 (KD Market Insights via COMTEX) -- According to a new market research report "CAR-T Cell Therapy Market Share, Size, Trends, Industry Analysis Report By Target Antigen (CD19/CD22, BCMA, Others); By Indication (Diffuse Large B-Cell Lymphoma (DLBCL), Acute Lymphoblastic Leukemia (ALL), Chronic Lymphocytic Leukemia (CLL), Multiple Myeloma (MM), Follicular Lymphoma (FL), Others); By Regions: Segment Forecast, 2020 - 2026". Published by Polaris Market Research. The global CAR-T Cell Therapy market size was valued at USD 482.2 Million in 2019 and is anticipated to reach over USD 8.92 billion by 2026 growing at a CAGR of 34.5% from 2020 to 2026
Market Overview -
This market report focuses on CAR-T which is one of the most innovative therapy available in the market which uses the patients' immune cells to fight cancer. The WBCs (white blood cells) are extracted - reengineered - injected again into the patient body to fight the malignant cells. This novel therapy has joined the bandwagon of the cancer cure treatments and it is expected to be one the sought-after therapies in the market. Majority of the companies have already started investing in them to gain a better market share in this industry.
No comments:
Post a Comment